The Cannabis Analytical Conundrum

February 1, 2016

Recently several states have legalized recreational and medical marijuana. This has created a confusing set of circumstances due to legalization at the state level, but cannabis is still an illegal schedule 1 drug at the federal level. This confusion also affects the development of analytical methods because there are no clear guidelines available to laboratories. This whitepaper will discuss the following topics: • Overview of state analytical requirements • Discussion of analytical method development for cannabinoids and related compounds of interest • Discussion of method performance